A Worldwide Pregnancy Safety Study to Assess Maternal, Foetal, and Infant Outcomes Following Exposure to Efgartigimod alfa during Pregnancy and/or BreastfeedingFirst published 26/02/2024 Last updated 13/03/2024 EU PAS number: EUPAS1000000005StudyOngoing
United BioSource Corporation (UBC)Switzerland First published: 25/04/2013Last updated 06/03/2024 InstitutionNon-Pharmaceutical companyENCePP partner